SCHEMBL9999737

SCHEMBL9999737

CCn1c(O)c(/N=N/c2cc(Nc3nc(Cl)nc(Nc4ccccc4)n3)ccc2S(=O)(=O)O)c(C)c(CS(=O)(=O)O)c1=O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ FUT8 Q9BYC5 1/20 0.44
▸ CA12 O43570 4/20 0.37
▸ CA1 P00915 4/20 0.37
▸ CA2 P00918 4/20 0.37
▸ CA9 Q16790 4/20 0.37
▸ CHAT P28329 3/20 0.36
▸ ENPP3 O14638 1/20 0.35
▸ ENPP1 P22413 1/20 0.35
▸ DHFR P00374 1/20 0.35
▸ USP2 O75604 1/20 0.35
▸ APEX1 P27695 1/20 0.35
▸ P2RX7 Q99572 1/20 0.34
▸ P2RX2 Q9UBL9 1/20 0.34
▸ EGFR P00533 1/20 0.34
▸ FGFR1 P11362 1/20 0.34
▸ ALDH1A1 P00352 1/20 0.34
▸ CYP1A2 P05177 1/20 0.34
▸ ENPP2 Q13822 1/20 0.33
▸ HPGDS O60760 1/20 0.33
▸ APP P05067 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18218146 1.00 FUT8 (0.44) FUT8CA12CA1CA2CA9
SCHEMBL13587215 0.94 FUT8 (0.43) FUT8CA12CA1CA2CA9
SCHEMBL12646574 0.94 FUT8 (0.43) FUT8CA12CA1CA2CA9
SCHEMBL12646576 0.94 FUT8 (0.44) FUT8CA12CA1CA2CA9
SCHEMBL12974339 0.94 FUT8 (0.44) FUT8CA12CA1CA2CA9
SCHEMBL14408278 0.94 FUT8 (0.37) FUT8CHATEGFRFGFR1ALDH1A1
SCHEMBL10017408 0.92 FUT8 (0.47) FUT8CA12CA1CA2CA9
SCHEMBL18218145 0.89 FUT8 (0.46) FUT8CA12CA1CA2CA9
SCHEMBL21239044 0.89 FUT8 (0.38) FUT8CA12CA1CA2CA9
SCHEMBL21239129 0.88 FUT8 (0.39) FUT8CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9758687-B2 Rheology modified ink and printing process DOVER EUROPE SÀRL (CH) 2017-09-12 — — US disclosed
US-9403987-B2 Charged particles BASF SE (DE) 2016-08-02 — — US disclosed
US-9403987-B2 Charged particles BASF SE (DE) 2016-08-02 — — US disclosed
US-20120229884-A1 CHARGED PARTICLES BASF SE (DE) 2012-09-13 — — US disclosed
US-20120229884-A1 CHARGED PARTICLES BASF SE (DE) 2012-09-13 — — US disclosed
US-20120021192-A1 RHEOLOGY MODIFIED INK AND PRINTING PROCESS SAWGRASS EUROPE SA (CH) 2012-01-26 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120229884-A1 CHARGED PARTICLES POLE3, POLD3, IPO4 FUT8 769/4885CA12 323/4885CA1 910/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback